181 related articles for article (PubMed ID: 20497694)
21. Do stem-like cells play a role in drug resistance of sarcomas?
Honoki K
Expert Rev Anticancer Ther; 2010 Feb; 10(2):261-70. PubMed ID: 20132001
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance.
Huang EH; Heidt DG; Li CW; Simeone DM
Surgery; 2007 Apr; 141(4):415-9. PubMed ID: 17383517
[No Abstract] [Full Text] [Related]
23. The clinical and therapeutic implications of cancer stem cell biology.
Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
[TBL] [Abstract][Full Text] [Related]
24. [Molecular targeted therapy for leukemic stem cells].
Kikushige Y
Nihon Rinsho; 2015 May; 73(5):811-5. PubMed ID: 25985636
[TBL] [Abstract][Full Text] [Related]
25. Cancer stem cells: a model in the making.
Marotta LL; Polyak K
Curr Opin Genet Dev; 2009 Feb; 19(1):44-50. PubMed ID: 19167210
[TBL] [Abstract][Full Text] [Related]
26. Mathematical models of cancer stem cells.
Michor F
J Clin Oncol; 2008 Jun; 26(17):2854-61. PubMed ID: 18539964
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms controlling pathogenesis and survival of leukemic stem cells.
Jordan CT; Guzman ML
Oncogene; 2004 Sep; 23(43):7178-87. PubMed ID: 15378078
[TBL] [Abstract][Full Text] [Related]
28. The stem cell hypothesis in head and neck cancer.
Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G
J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610
[TBL] [Abstract][Full Text] [Related]
29. Role of the tissue factor pathway in the biology of tumor initiating cells.
Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
[TBL] [Abstract][Full Text] [Related]
30. Evidence that high-migration drug-surviving MOLT4 leukemia cells exhibit cancer stem cell-like properties.
Huang X; Xiong M; Jin Y; Deng C; Xu H; An C; Hao L; Yang X; Deng X; Tu Z; Li X; Xiao R; Zhang Q
Int J Oncol; 2016 Jul; 49(1):343-51. PubMed ID: 27210806
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem cells in oncology.
Cetin I; Topcul M
J BUON; 2012; 17(4):644-8. PubMed ID: 23335519
[TBL] [Abstract][Full Text] [Related]
32. The role of stem and circulating cells in cancer metastasis.
Ghadially R
J Surg Oncol; 2011 May; 103(6):555-7. PubMed ID: 21480249
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cells and individualized therapy.
Chumsri S; Phatak P; Edelman MJ; Khakpour N; Hamburger AW; Burger AM
Cancer Genomics Proteomics; 2007; 4(3):165-74. PubMed ID: 17878520
[TBL] [Abstract][Full Text] [Related]
34. Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology.
ten Cate B; de Bruyn M; Wei Y; Bremer E; Helfrich W
Curr Drug Targets; 2010 Jan; 11(1):95-110. PubMed ID: 20017722
[TBL] [Abstract][Full Text] [Related]
35. Leukemic stem cells: a review.
O'Brien JA; Rizzieri DA
Cancer Invest; 2013 May; 31(4):215-20. PubMed ID: 23473080
[TBL] [Abstract][Full Text] [Related]
36. PTEN and leukemia stem cells.
Fragoso R; Barata JT
Adv Biol Regul; 2014 Sep; 56():22-9. PubMed ID: 24961634
[TBL] [Abstract][Full Text] [Related]
37. [Leukemia stem cell].
Iwasaki H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):280-4. PubMed ID: 24743272
[TBL] [Abstract][Full Text] [Related]
38. Cancer stem cells and chemoresistance: The smartest survives the raid.
Zhao J
Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500
[TBL] [Abstract][Full Text] [Related]
39. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.
Makena MR; Ranjan A; Thirumala V; Reddy AP
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165339. PubMed ID: 30481586
[TBL] [Abstract][Full Text] [Related]
40. [The essence of leukemia stem cells].
Goyama S
Rinsho Ketsueki; 2016; 57(10):1852-1859. PubMed ID: 27725580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
